Literature DB >> 8685092

[Histologic grading of chondrosarcoma. A qualitative and quantitative analysis of 74 cases of the Hamburg bone tumor register].

H Welkerling1, M Werner, G Delling.   

Abstract

Chondrosarcomas are frequent malignant bone tumors. Aside from different subtypes, such as dedifferentiated, mesenchymal and clear-cell chondrosarcoma, chondrosarcomas (classical chondrosarcoma) show different grades of differentiation. The borderline between chondroma and classical chondrosarcoma is not clearly defined. The same chondrosarcoma can be graded differently at different institutes. Standardized therapy concepts are currently in preparation. As the Hamburg Bone Tumor Registry is often consulted for chondrogenic tumors, the histological criteria are based on a series of 74 chondrosarcomas recorded there. The emphasis has been laid on a classification which can be used in daily routine and which is reproducible and in agreement with the classifications of other international groups. Grade I chondrosarcomas (50%) can be distinguished only by growth criteria. The nuclei are small and show high chromatin density. Grade II chondrosarcomas (42%) have medium-sized, regular nuclei with loose chromatin structure. The chondrocytes of grade III cases (8%) show polymorphic nuclei. Binucleas forms, the number of mitoses and cellularity all show considerable overlap for all three grades. So far there are no immunohistological and molecular biological methods for reliable differentiation. The therapeutic consequences of the classification into grades are thorough curettage, in the case of grade I tumors, or complete resection, for grade II and III cases. The long-term results, however, need to be confirmed by a larger number of cases. From 1991 to 1995 the method was applied and proved to be easily practicable in daily diagnostic routine. Some 104 cases of classical chondrosarcomas (grade I 53%, grade II 39%, grade III 8%) were analyzed. Two pathologists both assigned the same grade in 90% of cases.

Entities:  

Mesh:

Year:  1996        PMID: 8685092     DOI: 10.1007/s002920050130

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  6 in total

Review 1.  [Cartilage tumors. Classification, conditions for biopsy and histologic characteristics].

Authors:  G Delling; B Jobke; S Burisch; M Werner
Journal:  Orthopade       Date:  2005-12       Impact factor: 1.087

2.  A reproducible and simple grading system for classical chondrosarcomas. Analysis of 35 chondrosarcomas and 16 enchondromas with emphasis on recurrence rate and radiological and clinical data.

Authors:  Heike Welkerling; Susanne Kratz; Volker Ewerbeck; Günter Delling
Journal:  Virchows Arch       Date:  2003-09-25       Impact factor: 4.064

3.  Differentiating high-grade from low-grade chondrosarcoma with MR imaging.

Authors:  Hye Jin Yoo; Sung Hwan Hong; Ja-Young Choi; Kyung Chul Moon; Han-Soo Kim; Jung-Ah Choi; Heung Sik Kang
Journal:  Eur Radiol       Date:  2009-12       Impact factor: 5.315

4.  Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi-institutional study.

Authors:  Eiji Kozawa; Yoshihiro Nishida; Akira Kawai; Keiko Hayakawa; Nokitaka Setsu; Hiroyuki Kawashima; Shintaro Iwata; Hiroyuki Tsuchiya; Satoshi Tsukushi; Satoshi Takenaka; Jungo Imanishi; Ichiro Baba; Akihito Nagano; Takeshi Morii; Toshiharu Shirai; Koki Shimizu; Hirotaka Kawano
Journal:  Cancer Sci       Date:  2022-05-18       Impact factor: 6.518

5.  Can MRI differentiate between atypical cartilaginous tumors and high-grade chondrosarcoma? A systematic review.

Authors:  Claudia Deckers; Maarten J Steyvers; Gerjon Hannink; H W Bart Schreuder; Jacky W J de Rooy; Ingrid C M Van Der Geest
Journal:  Acta Orthop       Date:  2020-05-20       Impact factor: 3.717

6.  Malignant transformation of a phalangeal enchondroma into a recurrent grade II chondrosarcoma requiring successive transcarpal amputations: a case report.

Authors:  Ceyran Hamoudi; Benjamin Bouillet; Antoine Martins
Journal:  Case Reports Plast Surg Hand Surg       Date:  2022-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.